Literature DB >> 24469679

Immune-epithelial crosstalk at the intestinal surface.

Nadine Wittkopf1, Markus F Neurath, Christoph Becker.   

Abstract

The intestinal tract is one of the most complex organs of the human body. It has to exercise various functions including food and water absorption, as well as barrier and immune regulation. These functions affect not only the gut itself, but influence the overall health of the organism. Diseases involving the gastrointestinal tract such as inflammatory bowel disease and colorectal cancer therefore severely affect the patient's quality of life and can become life-threatening. Intestinal epithelial cells (IECs) play an important role in intestinal inflammation, infection, and cancer development. IECs not only constitute the first barrier in the gut against the lumen, they also constantly signal information about the gut lumen to immune cells, thereby influencing their behaviour. In contrast, by producing various antimicrobial peptides, IECs shape the microbial community within the gut. IECs also respond to cytokines and other mediators of immune cells in the lamina propria. Interactions between epithelial cells and immune cells in the intestine are responsible for gut homeostasis, and modulations of this crosstalk have been reported in studies of gut diseases. This review discusses the wide field of immune-epithelial interactions and shows the importance of immune-epithelial crosstalk in the intestine to gut homeostasis and the overall health status.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24469679     DOI: 10.1007/s00535-013-0929-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  130 in total

Review 1.  Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium.

Authors:  Claudia Günther; Helmut Neumann; Markus F Neurath; Christoph Becker
Journal:  Gut       Date:  2012-06-11       Impact factor: 23.059

2.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

3.  Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas.

Authors:  M Kojima; T Morisaki; A Uchiyama; F Doi; R Mibu; M Katano; M Tanaka
Journal:  Ann Surg Oncol       Date:  2001-06       Impact factor: 5.344

4.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

Authors:  Maria Van der Sluis; Barbara A E De Koning; Adrianus C J M De Bruijn; Anna Velcich; Jules P P Meijerink; Johannes B Van Goudoever; Hans A Büller; Jan Dekker; Isabelle Van Seuningen; Ingrid B Renes; Alexandra W C Einerhand
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

Review 5.  Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage.

Authors:  Sergei I Grivennikov; Michael Karin
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

6.  A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease.

Authors:  Yevgeny Zolotarevsky; Gail Hecht; Athanasia Koutsouris; Deborah E Gonzalez; Cliff Quan; Jeffrey Tom; Randall J Mrsny; Jerrold R Turner
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

7.  Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning.

Authors:  I D Iliev; E Mileti; G Matteoli; M Chieppa; M Rescigno
Journal:  Mucosal Immunol       Date:  2009-04-22       Impact factor: 7.313

8.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

9.  Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis.

Authors:  Lenka Frolova; Pavel Drastich; Pavel Rossmann; Klara Klimesova; Helena Tlaskalova-Hogenova
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

Review 10.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  16 in total

Review 1.  Molecular pathways driving disease-specific alterations of intestinal epithelial cells.

Authors:  Rocío López-Posadas; Markus F Neurath; Imke Atreya
Journal:  Cell Mol Life Sci       Date:  2016-09-13       Impact factor: 9.261

2.  The impact of exertional-heat stress on gastrointestinal integrity, gastrointestinal symptoms, systemic endotoxin and cytokine profile.

Authors:  Rhiannon M J Snipe; Anthony Khoo; Cecilia M Kitic; Peter R Gibson; Ricardo J S Costa
Journal:  Eur J Appl Physiol       Date:  2017-12-12       Impact factor: 3.078

3.  Macrophage-derived EDA-A2 inhibits intestinal stem cells by targeting miR-494/EDA2R/β-catenin signaling in mice.

Authors:  Lele Song; Renxu Chang; Xia Sun; Liying Lu; Han Gao; Huiying Lu; Ritian Lin; Xiaorong Xu; Zhanju Liu; Lixing Zhan
Journal:  Commun Biol       Date:  2021-02-16

4.  Tumour-associated changes in intestinal epithelial cells cause local accumulation of KLRG1+ GATA3+ regulatory T cells in mice.

Authors:  Holger Meinicke; Anna Bremser; Maria Brack; Paulina Akeus; Claire Pearson; Samuel Bullers; Katrin Hoffmeyer; Marc P Stemmler; Marianne Quiding-Järbrink; Ana Izcue
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

5.  Intestinal Metrnl released into the gut lumen acts as a local regulator for gut antimicrobial peptides.

Authors:  Zhi-Yong Li; Mao-Bing Fan; Sai-Long Zhang; Yi Qu; Si-Li Zheng; Jie Song; Chao-Yu Miao
Journal:  Acta Pharmacol Sin       Date:  2016-08-22       Impact factor: 6.150

6.  Activation of intestinal epithelial Stat3 orchestrates tissue defense during gastrointestinal infection.

Authors:  Nadine Wittkopf; Geethanjali Pickert; Ulrike Billmeier; Mousumi Mahapatro; Stefan Wirtz; Eva Martini; Moritz Leppkes; Markus Friedrich Neurath; Christoph Becker
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 7.  Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease.

Authors:  Yaron Ilan
Journal:  Clin Transl Immunology       Date:  2016-01-29

Review 8.  TTC7A: Steward of Intestinal Health.

Authors:  Sasha Jardine; Neel Dhingani; Aleixo M Muise
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-12-13

Review 9.  The interaction of Akkermansia muciniphila with host-derived substances, bacteria and diets.

Authors:  Tatsuro Hagi; Clara Belzer
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-14       Impact factor: 4.813

10.  Linking estrogen receptor β expression with inflammatory bowel disease activity.

Authors:  Marina Pierdominici; Angela Maselli; Barbara Varano; Cristiana Barbati; Paola Cesaro; Cristiano Spada; Angelo Zullo; Roberto Lorenzetti; Marco Rosati; Gabriella Rainaldi; Maria Rosaria Limiti; Luisa Guidi; Lucia Conti; Sandra Gessani
Journal:  Oncotarget       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.